{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-036587","form_type":"8-K","ticker":"MAIA","cik":"0001878313","company_name":"MAIA Biotechnology, Inc.","filed_at":"2024-02-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.201281+00:00","generated_at":"2026-06-06T02:41:07.121651+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"MAIA enters into ATM agreement to sell up to $1.445M of common stock via H.C. Wainwright","bullets":["ATM agreement with H.C. Wainwright to sell up to $1,445,000 of common stock.","Wainwright will receive 3.0% commission on gross proceeds from each sale.","Shares sold under existing effective shelf registration statement (Form S-3).","Agreement terminates upon sale of all shares or by either party at any time.","Company not obligated to sell any shares; may suspend solicitation at any time."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-036587","json":"https://secwatch.observer/filing/0001193125-24-036587.json","markdown":"https://secwatch.observer/filing/0001193125-24-036587.md","text":"https://secwatch.observer/filing/0001193125-24-036587.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1878313/000119312524036587/0001193125-24-036587-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1878313/000119312524036587/d756637d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T02:41:07.121651+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"94c1927a66fac132836d4855d756d7816b02e891","claim":"MAIA Biotechnology, Inc. entered into At The Market Offering Agreement with H.C. Wainwright & Co., LLC valued at up to $1,445,000 (effective 2024-02-14).","evidence_excerpt":"On February 14, 2024, MAIA Biotechnology, Inc. (“we,” “us,” the “Company” or “MAIA”) entered into an At The Market Offering Agreement (the “ATM Agreement”) with H.C. Wainwright & Co., LLC (“Wainwright”), to sell shares of our common stock, par value $0.0001 per share, (the “Shares”) having an aggregate sales price of up to $1,445,000","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1878313/000119312524036587/0001193125-24-036587-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"H.C. Wainwright & Co., LLC"},{"label":"Value","value":"up to $1,445,000"},{"label":"Effective","value":"2024-02-14"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}